Rita is a clinical pharmacist at TUH with extensive experience in both primary care and hospital settings, with a strong focus on patient-centred care. She has a proven track record of collaborating with multidisciplinary teams to optimise medication use, enhance patient safety, and improve healthcare outcomes. Passionate about empowering patients, Rita is dedicated to providing education and fostering engagement, ensuring that patients and/or caregivers are actively involved in their healthcare journey.

Trishna Bharadia is a multi-award winning patient engagement consultant and advocate with ~15 years of experience in the field. She works with multiple stakeholders, including pharma, medical communications agencies, publishers, academia, industry associations, and patient groups to better embed the patient voice into healthcare, research, and medicines development. Among various roles, she is a visiting lecturer in patient engagement at King’s College London, an Advisory Board member for the Patient Information Forum, a steering group member for Good Publication Practice (GPP), sits on editorial boards for several journals, and co-chairs the Working with Patients and Communities Forum at the Faculty of Pharmaceutical Medicine, where she is also an honorary member. Her main interests lie in good patient engagement practice and design/delivery of patient-focused projects; diversity, equity and inclusion in healthcare and research; and patient involvement in health information and scientific publications. A full list of her publications is available on ORCID.

Art has a background in neurophysiology and behavioural medicine. As an independent consultant, he specialises in regulatory strategy, Data Safety Monitoring Board management, medical writing, and bioethics. Art has held senior posts at a number of companies including Schering-Plough/Merck, Hoffmann-LaRoche, TFS, and Quintiles, and headed departments responsible for medical writing, publications, project management, and regulatory affairs. He also served as a Senior Research Fellow with the Centre for Innovation in Regulatory Sciences (CIRS). Art has extensive teaching experience and has presented to professional organisations (e.g. EMWA, AMWA, DIA), and corporate and academic audiences, worldwide. He spent 2 years heading Clinical Operations for an eDC ‘dot.com’ company, and has been active in Clinical Data Interchange Standards Consortium (CDISC) since its inception. He served as Chair of the Global Ethics and Regulatory Initiative (GERI) of the Alliance for Clinical Research Excellence and Safety (ACRES). He is a Founding Member of the Global Alliance of Publication Professionals (GAPP), a Past President of AMWA, and a Fellow of both AMWA and EMWA. Art served in a Senior Advisory capacity on the Budapest Working Group in developing the CORE Reference. He has a particular interest in bioethics in the context of clinical studies, is an adviser to an IRB, and serves on a number of task forces focusing on improving the drug development process while protecting the rights and safety of clinical study participants.

Biography

As a lawyer with extensive experience in the pharmaceutical industry, Franka Felsner is dedicated to helping her clients confidently and effectively navigate an ever-evolving regulatory landscape around the world. As Senior Legal Counsel at Boehringer Ingelheim, she provides expert legal support for all aspects of clinical development, with a particular focus on Informed Consent Forms in the European Union and beyond. Before joining Boehringer Ingelheim, Franka worked for an international law firm in London, Brussels, and Frankfurt, and holds a law degree from the University of Oxford.